BusinessEarth Science Tech Commences Pre-Launch, Double-Blind Human Clinical Trials for New CBD Formula to Fight U.S. Opioid EpidemicBy Nasdaq OMXNov 28, 2017, 1:01 PM UTC
BusinessEarth Science Tech Inc. Announces New Corporate Facility & participates in its First Trade Expo in DecemberBy Nasdaq OMXNov 16, 2017, 1:00 PM UTC
BusinessEarth Science Tech, Inc. Signs Agreement with TransBiotech to start in Vitro & in Vivo in Phase II for Nutraceutical PatentsBy Nasdaq OMXNov 14, 2017, 1:01 PM UTC
BusinessEarth Science Tech, Inc. Announces Partnership with Bionatus to Help Manufacture, Distribute, & Continue Further R&D on Cannabis (CBD) ProductsBy Nasdaq OMXAug 22, 2017, 12:25 PM UTC
BusinessAXIM Biotech Enters Term Sheet Agreement With US API Company to Develop Bioequivalent Product to MarinolBy Nasdaq OMXMar 28, 2017, 1:01 PM UTC
BusinessEarth Science Tech Inc. and Cannabis Therapeutics Inc. to hold High-Level R&D Strategy Session in Laval, Qc and announces Dr. Moutih Rafei, PhD, as a new member of the Advisory BoardBy Nasdaq OMXFeb 28, 2017, 1:00 PM UTC
BusinessOxford University Press Study Points to Effective and Inexpensive Infertility TreatmentBy Nasdaq OMXFeb 17, 2016, 6:32 PM UTC
